Scientific interests
- Molecular biology, molecular endocrinology, molecular mechanisms of action of anticancer drugs, intracellular signaling, molecular mechanisms of hormonal regulation, lipid regulatory function.
Education
Institution
Yerevan State University
Faculty
Department of Biophysics, Faculty of Biology
Date
-
Degree name
Qualified specialist
Scientific Rank/degree
Institution
Ph. D. (Candidate of Biol. Sci.), Biochemistry
Date
1989
Degree name
Candidate
Specialty
Biological sciences
Scientific Supervisor
Panosyan Garegin Harutyun, Gevorkyan Emil Sos
Research Topic
Composition and metabolism of lipids in some nuclear structures of rats liver under the hydrocortisone actioon
Language skills
Հայերեն
Русский
English
Work experience
Institution
Department of Biophysics, Faculty of Biology, Yerevan State University
Period of time
-
Rank/degree
Associate Professor (Docent), Department of Biophysics, Faculty of Biology, Yerevan State University
Institution
Department of Biophysics, Faculty of Biology, Yerevan State University
Period of time
-
Rank/degree
Assistant Professor, Department of Biophysics, Faculty of Biology, Yerevan State University
Institution
Department of Biophysics, Faculty of Biology, Yerevan State University
Period of time
-
Rank/degree
Senior researcher of scientific topics of the Department of Physics (200-262; 0041; 0641) and Scientific Research Laboratory of Biophysics of Subcellular Structures.
Participation in international conferences and seminars
-
27th Wilhelm Bernhard Workshop on the Cell Nucleus
Czech Republic (the)
-
A joint Biochemical Society/FEBS Focused Meeting. Signalling 2015: Cellular Functions of Fhosphoinositides and Inositol Phosphates.
United Kingdom of Great Britain and Northern Ireland (the)
-
14th Euro Fed Lipid Congress
Belgium
-
6th EUROPEAN WORKSHOP ON LIPID MEDIATORS
Germany
-
ICSB INTERNATIONAL CONFERENCE SMART BIO
Lithuania
-
7th European Workshop on Lipid Mediators
Belgium
Albany 2019:The 20th Conversation. Nuclear structure and dynamics
United States of America (the)
-
2nd FEBS Advanced Lecture Course on Oncometabolism,From Conceptual Knowledge to Clinical Applications
Portugal
-
8 th European Workshop on Lipid Mediators (8EWLM)
Sweden
Other information
2008 Docent Highest Attestation Commission of RA
Publications
Article
Content of neutral lipids in rat liver and thymus chromatin under the in vivo action of cisplatin.
Article
CISPLATIN ACTION ON PHOSPHOLIPID COMPOSITION IN NUCLEAR FRACTION OF RAT LIVER CELLS
Conference
Cisplatin action on polyphosphoinositides content in rat liver and thymus nuclear membranes.
Conference
ЧУВСТВИТЕЛЬНОСТЬ ОТДЕЛЬНЫХ ФРАКЦИЙ ФОСФОЛИПИДОВ ХРОМАТИНА К ЛЕТОК МОЗГА КРЫС К IN VIVO ВОЗДЕЙСТВИЮ ЦИСПЛАТИНА
Conference
Effect of Cisplatin on Rat Liver Nuclear Membrane Phospholipids as Integral Participants in Signal Transduction
Conference
ALTERATION IN CONTENT OF RAT BRAIN CHROMATIN NEUTRAL LIPIDS UNDER THE ACTION OF CISPLATIN
Conference
Alterations In Sphingomyelin:Phosphatidylcholine Ratio In Chromatin Preparations From Rat Liver And Thymus Cells After The Cisplatin In Vivo Action
Conference
Alterations in sphingomyelin:phosphatidylcholine ratio in chromatin preparations from rat liver and thymus cells after the cisplatin in vivo action
Conference
CHANGES IN POLYPHOSPHOINOSITIDES CONTENT IN NUCLEAR FRACTION OF RAT LIVER AND THYMUS CELLS AFTER THE ACTION OF CISPLATIN
Conference
THE SENSITIVITY OF CHOLINE INCLUSIVE LIPIDS OF RAT BRAIN AND KIDNEY CHROMATIN TO CISPLATIN IN VIVO ACTION.
Conference
Cisplatin and Estradiol Joint Action on Quantities of Rat Brain Chromatin Phospholipids
Conference
Antioxidant Enzyme Catalase Activity of Rat Kidney Cells Nuclear Fraction After the Cisplatin and Estradiol Separate and Joint Action.
Conference
Cisplatin and estradiol separate and joint action on female
Conference
ESTRADIOL AND CISPLATIN JOINT ACTION ON FEMALE RAT BRAIN NUCLEAR PHOSPHOLIPIDS CONTENT
Conference
The sensitivity of cholin inclusive phospholipids of rat brain cells nuclear to progesterone in vivo action.
Conference
Alterations of rat brain nuclear phospholipids content under the combined action of cisplatin and progesterone
